Nvidia CPU comments read positively for this chip stock: analyst

Jefferies reiterated a Buy rating and $290 price target on Arm, citing Nvidia’s visibility for $20 billion of standalone Vera CPU sales this year and a potential $200 billion TAM for the chip. The note argues this supports a stronger Arm royalty outlook, with data-center CPU royalty growth expected around 20% this year and hyperscaler share potentially rising from 50% toward 60%. Jefferies also sees Arm’s AGI CPU revenue outlook as conservative, forecasting $1.4 billion in FY28 versus company guidance of $1 billion.

Analysis

The market’s first-order read is that ARM gets a royalty uplift, but the larger second-order effect is a faster normalization of Arm as the default architecture for AI infrastructure, not just edge devices. That expands Arm’s negotiating leverage with hyperscalers and OEMs, because once multiple platform vendors standardize on Arm, switching costs rise across software, silicon validation, and fleet management. In other words, the valuation debate shifts from “can Arm monetize smartphones less badly?” to “how quickly does Arm become embedded in the CPU layer of AI data centers.”

For Nvidia, the signal is more nuanced: standalone CPU revenue helps validate the Vera platform, but it also hints at a future where Nvidia is selling more of the compute stack while giving up some architectural rents to Arm. That is still strategically positive if it accelerates system adoption and expands the installed base around Nvidia’s GPU-led rack architecture. The beneficiary set likely extends to cloud infrastructure suppliers and EDA/IP vendors, while x86 incumbents face a slow but real share bleed in the highest-growth part of server demand.

The key risk is duration mismatch: the stock can rerate on the narrative now, while the revenue inflection is back-half and multi-year. If AI capex pauses, or if hyperscalers slow deployment cadence to digest prior-generation systems, the “AGI CPU” story can get pushed out without necessarily breaking the long-term thesis. The consensus may be underestimating how much of ARM’s upside is already being pulled forward by investors, versus how much execution evidence still needs to arrive over the next 6-12 months.

Key Decisions for Investors

• Long ARM on pullbacks over the next 1-4 weeks; best risk/reward is to buy weakness after the initial gap-up cools, targeting a multi-quarter re-rating as AI CPU content becomes a larger part of the mix.
• Pair trade: long ARM / short a basket of mature x86 server exposure for a 3-6 month view; thesis is incremental AI infrastructure share shift toward Arm, with the short leg cushioning broader semiconductor beta.
• Add selective NVDA exposure on any post-earnings consolidation, not chase strength; the Vera signal supports platform durability, but the cleaner upside is in ecosystem monetization rather than immediate incremental revenue.
• Use call spreads in ARM rather than outright stock if implied volatility is elevated; the catalyst is narrative and multiple expansion over weeks to months, not a near-term earnings step-function.
• For cautious accounts, wait for confirmation in hyperscaler capex commentary over the next two earnings cycles before increasing ARM size; the thesis weakens materially if data-center rollout commentary turns more conservative.